Literature DB >> 20715930

Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model.

Karen L Laurie1, Louise A Carolan, Deborah Middleton, Sue Lowther, Anne Kelso, Ian G Barr.   

Abstract

BACKGROUND: An age bias toward children and young adults has been reported for infection and hospitalizations with pandemic H1N1 influenza (A[H1N1]pdm) in the 2009 and 2010 influenza seasons in the Southern and Northern Hemispheres. Serological analysis of prepandemic samples has shown a higher incidence of cross-reactive antibodies to A(H1N1)pdm virus in older populations; conserved T cell epitopes between viruses have been identified. The contribution of preexisting immunity to seasonal influenza to protection against A(H1N1)pdm infection was analyzed in a ferret model.
METHODS: Ferrets were pre-infected with influenza A viruses and/or vaccinated with inactivated influenza viruses with adjuvant. Infection after challenge was assessed by measuring shedding virus, transmission to naive animals, and seroconversion.
RESULTS: Homologous vaccination reduced the incidence of infection and delayed transmission. Pre-infection with virus induced sterilizing immunity to homologous challenge. One prior infection with seasonal influenza A virus improved clearance of A(H1N1)pdm virus. Prior infection with A(H1N1)pdm virus reduced shedding after seasonal influenza A challenge. Two infections with seasonal influenza A viruses reduced the incidence of infection, the amount and duration of virus shedding, and the frequency of transmission following A(H1N1)pdm challenge.
CONCLUSION: These data suggest the reduced incidence and severity of infection with A(H1N1)pdm virus in the adult population during the 2009-2010 influenza season may be a result of previous exposure to seasonal influenza A viruses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20715930     DOI: 10.1086/656188

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  60 in total

1.  Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.

Authors:  Yuan Fang; David Banner; Alyson A Kelvin; Stephen S H Huang; Christopher J Paige; Steven A Corfe; Kevin P Kane; R Chris Bleackley; Thomas Rowe; Alberto J Leon; David J Kelvin
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

2.  On the extinction probability in models of within-host infection: the role of latency and immunity.

Authors:  Ada W C Yan; Pengxing Cao; James M McCaw
Journal:  J Math Biol       Date:  2016-01-09       Impact factor: 2.259

3.  Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Authors:  Danuta M Skowronski; Travis S Hottes; Janet E McElhaney; Naveed Z Janjua; Suzana Sabaiduc; Tracy Chan; Beth Gentleman; Dale Purych; Jennifer Gardy; David M Patrick; Robert C Brunham; Gaston De Serres; Martin Petric
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

4.  Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice.

Authors:  Leonard Moise; Ryan Tassone; Howard Latimer; Frances Terry; Lauren Levitz; John P Haran; Ted M Ross; Christine M Boyle; William D Martin; Anne S De Groot
Journal:  Hum Vaccin Immunother       Date:  2013-09-17       Impact factor: 3.452

5.  Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.

Authors:  Rogier Bodewes; Pieter L A Fraaij; Martina M Geelhoed-Mieras; Carel A van Baalen; Harm A W M Tiddens; Annemarie M C van Rossum; Fiona R van der Klis; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

6.  Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets.

Authors:  Grace L Chen; Ji-Young Min; Elaine W Lamirande; Celia Santos; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Infect Dis       Date:  2011-01-21       Impact factor: 5.226

7.  Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.

Authors:  Michela Brazzoli; Diletta Magini; Alessandra Bonci; Scilla Buccato; Cinzia Giovani; Roland Kratzer; Vanessa Zurli; Simona Mangiavacchi; Daniele Casini; Luis M Brito; Ennio De Gregorio; Peter W Mason; Jeffrey B Ulmer; Andrew J Geall; Sylvie Bertholet
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

8.  Antigenically Diverse Swine Origin H1N1 Variant Influenza Viruses Exhibit Differential Ferret Pathogenesis and Transmission Phenotypes.

Authors:  Joanna A Pulit-Penaloza; Joyce Jones; Xiangjie Sun; Yunho Jang; Sharmi Thor; Jessica A Belser; Natosha Zanders; Hannah M Creager; Callie Ridenour; Li Wang; Thomas J Stark; Rebecca Garten; Li-Mei Chen; John Barnes; Terrence M Tumpey; David E Wentworth; Taronna R Maines; C Todd Davis
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.

Authors:  Joanna A L Choo; Jingxian Liu; Xinyu Toh; Gijsbert M Grotenbreg; Ee Chee Ren
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

10.  Promotion of Hendra virus replication by microRNA 146a.

Authors:  Cameron R Stewart; Glenn A Marsh; Kristie A Jenkins; Michael P Gantier; Mark L Tizard; Deborah Middleton; John W Lowenthal; Jessica Haining; Leonard Izzard; Tamara J Gough; Celine Deffrasnes; John Stambas; Rachel Robinson; Hans G Heine; Jackie A Pallister; Adam J Foord; Andrew G Bean; Lin-Fa Wang
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.